Elwood Capital Partners’s Rentokil RTO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-625
Closed -$1.58M 27
2024
Q4
$1.58M Buy
+625
New +$15.8K 1.56% 20

Other funds holding RTO

Elwood Capital Partners's RTO Position: Q2 2026 in Review

Elwood Capital Partners reduced its Rentokil (RTO) stake by 44% in Q2 2026, selling an estimated $3.17M and leaving 125,180 shares worth $3.58M. The position accounts for 1.77% of the portfolio, ranked #22.

Elwood Capital Partners first reported a position in RTO in Q4 2024 and has held it in 7 quarters since. The position peaked at $8.11M in Q4 2025. 283 funds tracked by Wall St. Rank hold RTO as of Q2 2026.

  • Elwood Capital Partners held 125,180 shares of Rentokil worth $3.58M as of Q2 2026.
  • Elwood Capital Partners sold 100,000 Rentokil shares in Q2 2026, an estimated $3.17M.
  • Rentokil made up 1.77% of Elwood Capital Partners's portfolio in Q2 2026, its #22 holding.
  • Elwood Capital Partners first reported a position in Rentokil in Q4 2024 and has held it in 7 quarters since.
  • Elwood Capital Partners's Rentokil position peaked at $8.11M in Q4 2025.
  • 283 funds tracked by Wall St. Rank held Rentokil as of Q2 2026.

Based on Elwood Capital Partners's 13F filing for Q2 2026, filed 13 Aug 2026.